References
Askew YS,
Pak SC,
Luke CJ, et al.
(2001)
SERPINB12 is a novel member of the human ov‐serpin family that is widely expressed and inhibits trypsin‐like serine proteinases.
Journal of Biological Chemistry
276: 49320–49330.
Bird CH,
Sutton VR,
Sun J, et al.
(1998)
Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B‐mediated apoptosis without perturbing the Fas cell death pathway.
Molecular Cell Biology
18: 6387–6398.
Dougherty KM,
Pearson JM,
Yang AY, et al.
(1999)
The plasminogen activator inhibitor‐2 gene is not required for normal murine development or survival.
Proceedings of the National Academy of Sciences of the United States of America
96: 686–691.
Duggan C,
Kennedy S,
Kramer MD, et al.
(1997)
Plasminogen activator inhibitor type 2 in breast cancer.
British Journal of Cancer
76: 622–627.
Huntington JA,
Read RA and
Carrell RW
(2000)
Structure of a serpin–protease complex shows inhibition by deformation.
Nature
407: 923–926.
Jin L,
Abrahams JP,
Skinner R, et al.
(1998)
The anticoagulant activation of antithrombin by heparin.
Proceedings of the National Academy of Sciences of the United States of America
94: 14683–14688.
Keijer J,
Ehrlich HJ,
Linders M,
Preissner KT and
Pannekoek H
(1991)
Vitronectin governs the interaction between plasminogen activator inhibitor 1 and tissue‐type plasminogen activator.
Journal of Biological Chemistry
266: 10700–10707.
Rees DD,
Rogers RA,
Cooley J, et al.
(1999)
Recombinant human monocyte/neutrophil elastase inhibitor protects rat lungs against injury from cystic fibrosis airway secretions.
American Journal of Respiratory Cell and Molecular Biology
20: 69–78.
Remold‐O'Donnell E
(1993)
The ovalbumin family of serpin proteins.
FEBS Letters
315: 105–108.
Riewald M and
Schleef RR
(1996)
Human cytoplasmic antiproteinase neutralizes rapidly and efficiently chymotrypsin and trypsin‐like proteinases utilizing distinct reactive site residues.
Journal of Biological Chemistry
271: 14526–14532.
Scott FL,
Eyre HJ,
Lioumi M, et al.
(1999)
Human ovalbumin serpin evolution: phylogenic analysis, gene organization, and identification of new PI‐8‐related genes suggest that two interchromosomal and several intrachromosomal duplications generated the gene clusters at 18q21–q23 and 6p25.
Genomics
62: 490–499.
Zhang M,
Volpert O,
Shi YH and
Bouck N
(2000)
Maspin is an angiogenesis inhibitor.
Nature Medicine
6: 196–199.
Further Reading
Antalis TM,
La Linn M,
Donnan K, et al.
(1998)
The serine proteinase inhibitor (serpin) plasminogen activation inhibitor type 2 protects against viral cytopathic effects by constitutive interferon alpha/beta priming.
Journal of Experimental Medicine
187: 1799–1811.
Belin D
(1993)
Biology and facultative secretion of plasminogen activator inhibitor‐2.
Thrombosis and Haemostasis
70: 144–147.
Bird PI
(1999)
Regulation of pro‐apoptotic leucocyte granule serine proteinases by intracellular serpins.
Immunology and Cell Biology
77: 47–57.
Grigoryev SA,
Bednar J and
Woodcock CL
(1999)
MENT, a heterochromatin protein that mediates higher order chromatin folding, is a new serpin family member.
Journal of Biological Chemistry
274: 5626–5636.
Silverman GS,
Bird PI,
Carrell RW, et al.
(2001)
The serpins are an expanding superfamily of structurally similar but functionally diverse proteins.
Journal of Biological Chemistry
276: 33293–33296.
Stein PE and
Carrell RW
(1995)
What do dysfunctional serpins tell us about molecular mobility and disease?
Structural Biology
2: 96–113.
Zou Z,
Anisowicz A,
Hendrix MJC, et al.
(1994)
Maspin, a serpin with tumour‐supressing activity in human mammary epithelial cells.
Science
263: 526–529.